Investors who bought shares of Amgen (NASDAQ: AMGN) five years ago are probably a happier bunch than those who went for Johnson & Johnson (NYSE: JNJ). Amgen stock rose around 40% more than J&J’s did during the period.
So far in 2017, Amgen continues to outperform Johnson & Johnson. But which is the better stock for investors to buy right now? Here’s how the two healthcare stocks compare.
Image source: Getty Images.